Ototoxicity After Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy in Children With Medulloblastoma-Reference-Cited by-同舟云学术

Ototoxicity After Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy in Children With Medulloblastoma

Published:2010-12 Issue:5 Volume:78 Page:1445-1450
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Paulino Arnold C.,Lobo Mark,Teh Bin S.,Okcu M. Fatih,South Michael,Butler E. Brian,Su Jack,Chintagumpala Murali

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial;Gajjar;Lancet Oncol,2006

2. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma;Merchant;Int J Radiat Oncol Biol Phys,2008

3. Posterior fossa boost in medulloblastoma: An analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy;Paulino;Int J Radiat Oncol Biol Phys,2000

4. Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity;Huang;Int J Radiat Oncol Biol Phys,2003

5. The challenge of conformal radiotherapy in the curative treatment of medulloblastoma;Tarbell;Int J Radiat Oncol Biol Phys,2000

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric analysis of hearing loss after cranial radiation therapy in children: A single-institution study from the French national registry PediaRT;Radiotherapy and Oncology;2024-08

2. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma;Neuro-Oncology;2024-06-25

3. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier;Cancer Medicine;2023-11-23

4. Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review;International Journal of Radiation Oncology*Biology*Physics;2023-10

5. The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent CNS and head‐and‐neck cancer patients: A report from the PanCareLIFE consortium;International Journal of Cancer;2023-09-15